A CLINICAL TRIAL TO STUDY THE EFFECTS OF 2 DRUGS, CARBETOCIN AND OXYTOCIN ON PREVENTION OF POSTPARTUM BLOOD LOSS
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2023/03/050602
- Lead Sponsor
- BPS GOVT. MEDICAL COLLEGE FOR WOMEN , KHANPUR KALA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Term pregnancy (37 weeks to 40 weeks)
Cephalic presentation
Atleast one risk factor for developing atonic PPH- uterine overextension (macrosomia , polyhydroamnios , multiple pregnancy)
prolonged labor
Anemia (Hb <8gm/dl)
Previous history of PPH
Grand multipara
Labor induction or augmentation with oxytocin
Pregnancy complications like hypertension , gestational diabetes
Patients undergoing Cesarean section
Traumatic & other causes of PPH
Instrumental Delivery
Coagulation Disorders
Antepartum Hemorrhage (placenta previa , abruptio)
HELLP and Eclampsia
Precipitate Labor
History of any cardiac , renal , liver disease , epilepsy
Patients who have respiratory problems Eg : Asthmatics
Known allergies to oxytocin and/or carbetocin
Those without risk factor
Refused to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy of both drugs in preventing atonic post partum hemorrhageTimepoint: 2 hours post delivery
- Secondary Outcome Measures
Name Time Method mount of blood loss during delivery , effects on Hemoglobin values pre and post delivery , safety and side effects of treatment <br/ ><br>Timepoint: 24 hours post delivery